This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BEIJING, Dec. 11, 2012 (GLOBE NEWSWIRE) --
Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that it has obtained a medical equipment procurement agreement valued at approximately RMB 2 million. The procurement agreement is with Beijing Kanglian Medicine Company and is part of the China Development Bank's ("CDB") Rural Medical and Healthcare Infrastructure Project in Longhua County, Hebei province.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical said, "Dehaier has implemented several Rural Medical and Healthcare Infrastructure Projects with Beijing Kanglian Medicine Company. These cooperation have given us valuable experience in bidding, implementation and after-sales service for these government-initiated projects. In accordance with the CDB's mandate to support rural medical and healthcare construction, the CDB plans to offer preferential loans worth 7 billion RMB in the aggregate to county medical institutions and clinics, which will facilitate purchases by county hospitals of medicine and medical equipment. Looking at current policies and trends, we believe the government will continue to invest more capital and resources into medical and healthcare infrastructure programs. For this reason, we will keep focusing on this area for future opportunities."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the Hebei procurement contract. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Dehaier Medical Systems Limited